Marken’s Direct-to-Patient (DTP) distribution services are now actively delivering to and from 94 cities in India and are expected to be available in 110 cities by the end of May. The service is in response to India’s government lock down, which has now been extended until May 18th. Marken’s deliveries of medicine to patients confined to their homes while enrolled in a clinical trial is a continuation of the company’s strategy to bring clinical trials closer to patient’s homes....